Pressure is the enemy of a healing diabetic foot ulcer. In a foot that has lost protective sensation to peripheral neuropathy, every step drives repetitive mechanical load into the wound bed, disrupting new tissue before it can consolidate. Removing that load — a practice clinicians call “offloading” — is one of the most powerful, evidence-based interventions available for healing plantar diabetic foot ulcers and preventing the amputations that too often follow them. Yet decades of research show that the most effective offloading methods remain widely underused. This article reviews what the peer-reviewed literature says about how offloading works, which devices heal ulcers fastest, and why the gap between evidence and everyday practice matters.
Why offloading is central to wound healing
Plantar neuropathic ulcers develop where repetitive pressure concentrates over bony prominences in an insensate foot. Because the patient feels no pain, walking continues unchecked and the wound is re-injured with each stride. Effective healing therefore depends on redistributing or eliminating that pressure. A comprehensive systematic review by Lazzarini and colleagues, which informed the International Working Group on the Diabetic Foot (IWGDF) guidelines, examined 165 studies and concluded that mechanical offloading is a cornerstone of care for plantar forefoot and midfoot ulcers, with strong evidence favouring devices that the patient cannot remove.
The evidence hierarchy of offloading devices
Not all offloading is equal. The strongest evidence — drawn from multiple meta-analyses and randomized controlled trials — supports non-removable, knee-high devices as the first-choice treatment for plantar neuropathic forefoot and midfoot ulcers. Two options share this top tier: the total contact cast (TCC), a close-fitting cast that distributes load across the entire lower leg and foot, and the non-removable knee-high walker, a prefabricated boot rendered irremovable. Lazzarini and colleagues found these two approaches to be equally effective, and both outperform removable devices and therapeutic footwear.
The reason non-removable devices work better is largely behavioural. A removable boot only offloads the wound while it is being worn, and adherence is often poor; a device the patient cannot take off guarantees the wound is protected at every step. The same review found that removable knee-high and ankle-high devices are roughly equivalent in healing, though knee-high versions reduce plantar pressure and overall walking activity more effectively, making them the preferred second choice when a non-removable device is unsuitable.
Pressure-mapping and newer cast designs
Biomechanical studies continue to refine our understanding of how these devices perform. A 2025 plantar-pressure analysis by Carter and colleagues, dividing the sole into nine regions, reaffirmed that the TCC remains the gold standard and first line for offloading, while quantifying meaningful pressure reductions across most of the foot with cast, brace, and walker options. Innovation has also aimed at the TCC’s practical drawbacks. A retrospective comparison by Vierhout and colleagues found that a non-removable total contact softcast achieved healing rates comparable to a conventional TCC, with a trend toward shorter healing times, suggesting that lighter, better-tolerated cast systems may preserve efficacy while improving patient comfort.
Offloading in Charcot neuroarthropathy
Offloading is equally critical in active Charcot neuro-osteoarthropathy, a destructive process in which the neuropathic foot fractures and deforms, often without pain. Here casting is used not only to heal skin but to immobilize the foot and prevent collapse. A 2024 cohort study by Schoug and colleagues reported that initiating total contact casting in the earliest inflammatory phase (stage 0), before fractures and deformity are established, was associated with significantly shorter casting duration, a lower risk of recurrent Charcot events, and a reduced need for reconstructive surgery. The finding underscores that timing, not just technique, shapes outcomes.
The evidence-to-practice gap
Despite consistent, high-quality evidence, the best offloading devices are strikingly underused. A survey of Swedish prosthetic and orthotic clinics by Gigante and colleagues found that 86% of practitioners treated plantar neuropathic ulcers with modified off-the-shelf footwear and insoles — an approach the IWGDF specifically recommends against as a primary healing device — while only 20% offered a TCC and none used a non-removable knee-high walker. Many practitioners were unaware that these were the recommended gold standards. The authors described a pattern of care almost exactly opposite to evidence-based guidelines, driven partly by limited awareness. Barriers such as casting time, staff training, and concerns about applying casts to feet with poor circulation contribute to this hesitancy, though windowed and modified cast designs have been developed to allow wound inspection in higher-risk patients.
Key takeaways
The clinical message from the past decade of research is consistent. Offloading is not an adjunct to diabetic foot ulcer care — it is a primary determinant of whether a plantar wound heals. Non-removable, knee-high devices, whether a total contact cast or an irremovable walker, are the best-supported first-choice interventions for neuropathic forefoot and midfoot ulcers, with removable knee-high devices as the preferred fallback. In active Charcot foot, early casting improves outcomes and may spare patients later surgery. Perhaps most importantly, the literature reveals a persistent gap between what evidence recommends and what is routinely delivered, meaning that wider awareness and adoption of proven offloading methods represent a significant, unrealized opportunity to heal wounds faster and prevent amputations.
References
Lazzarini PA, Jarl G, Gooday C, et al. Effectiveness of offloading interventions to heal foot ulcers in persons with diabetes: a systematic review. Diabetes/Metabolism Research and Reviews. 2020;36(S1):e3275.
Bus SA, Monteiro-Soares M, Game F, et al. Standards for the development and methodology of the 2023 IWGDF guidelines. Diabetes/Metabolism Research and Reviews. 2023;40(3):e3656.
Carter SL, Law JHM, Seyler N, et al. Removable and Nonremovable Off-Loading Devices. Journal of the American Podiatric Medical Association. 2025;115(3).
Vierhout BP, Visser R, Hutting KH, et al. Comparing a non-removable total contact cast with a non-removable softcast in diabetic foot ulcers: a retrospective study of a prospective database. Diabetes Research and Clinical Practice. 2022;191:110036.
Schoug J, Katzman P, Fagher K, Löndahl M. Charcot Foot Offloading in Stage 0 Is Associated With Shorter Total Contact Cast Treatment and Lower Risk of Recurrence and Reconstructive Surgery: A Pilot Study. Diabetes Care. 2024;47(2):252–258.
Gigante I, Sigurjónsdóttir ED, Jarl G, Hellstrand Tang U. Offloading of diabetes-related neuropathic foot ulcers at Swedish prosthetic and orthotic clinics. Diabetes/Metabolism Research and Reviews. 2023;39(4):e3611.
Comments
